Prevalence of malnutrition and obesity among cystic fibrosis patients

Pediatrics International

Volumn 56, Issue 1, 2014, Pages 89-94

  Panagopoulou, Paraskevi ^a   Fotoulaki, Maria ^a   Nikolaou, Aristidis ^a,b   Nousia Arvanitakis, Sanda ^a  

^a PAPAGEORGIOU GENERAL HOSPITAL   (Greece)

^b KAT HOSPITAL   (Greece)

Author keywords

body composition; cystic fibrosis; malnutrition; nutritional status; obesity

Indexed keywords

ADOLESCENCE; ADOLESCENT; ADULT; ANTHROPOMETRY; ARTICLE; ASSOCIATION; BACTERIAL COLONIZATION; BODY COMPOSITION; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHILD; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYSTIC FIBROSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FORCED EXPIRATORY VOLUME; GENE MUTATION; GENOTYPE; HUMAN; KOLMOGOROV SMIRNOV TEST; LIPID BLOOD LEVEL; LIVER DISEASE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; METABOLIC SYNDROME X; NUTRITIONAL STATUS; OBESITY; OVERALL SURVIVAL; PANCREAS FUNCTION; PANCREAS INSUFFICIENCY; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; PSEUDOMONAS; RESPIRATORY FUNCTION; SCHOOL CHILD; SCORING SYSTEM; SEX RATIO; SPIROMETRY; TERTIARY CARE CENTER; YOUNG ADULT; COMPLICATION; GREECE; RETROSPECTIVE STUDY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; CYSTIC FIBROSIS; FEMALE; GREECE; HUMANS; MALE; MALNUTRITION; NUTRITIONAL STATUS; OBESITY; PREVALENCE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84890348439     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/ped.12214     Document Type: Article

References (38)

1. Simmons F,. The changing epidemiology of cystic fibrosis. J. Pediatr. 1993; 122: 1-9.
2. CFMDB Statistics. Cystic Fibrosis Mutation Database. 2010. [Cited 10 August 2012.] Available from URL: http://www.genet.sickkids.on.ca/app
3. Riggs AC, Seaquist ER, Moran A,. Guidelines for the diagnosis and therapy of diabetes mellitus in cystic fibrosis. Curr. Opin. Pulm. Med. 1999; 5: 378-382.
4. Balassopoulou A, Loukopoulos D, Kollia P, et al. Cystic fibrosis in Greece: Typing with DNA probes and identification of the common molecular defect. Hum. Genet. 1990; 85: 393-394.
5. Neijens H,. Cystic fibrosis, pathophysiological and clinical aspects. Eur. J. Pediatr. 1990; 149: 742-746.
6. Davis P, Drumm M, Konstan M,. Cystic fibrosis. Am. J. Respir. Crit. Care Med. 1996; 154: 1229-1256.
7. Colombo C, Apostolo MG, Assaisso M, Roman B, Bottani P,. Liver disease in cystic fibrosis. Neth. J. Med. 1992; 41: 119-122.
8. Nousia-Arvanitakis S, Fotoulaki M, Economou H, Xefteri M, Galli-Tsinopoulou A,. Long-term prospective study of the effect of ursodeoxycholic acid on cystic fibrosis-related liver disease. J. Clin. Gastroenterol. 2001; 32: 324-328.
9. Pencharz PB, Durie PR,. Pathogenesis of malnutrition in cystic fibrosis, and its treatment. Clin. Nutr. 2000; 19: 387-394.
10. Sinaasappel M, Stern M, Littlewood J, et al. Nutrition in patients with cystic fibrosis: A European Consensus. J. Cyst. Fibros. 2002; 1: 51-75.
11. Corey M, McLaughlin F, Williams M, Levison H,. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J. Clin. Epidemiol. 1988; 41: 588-591.
12. Steinkamp G, Wiedemann B,. Relationship between nutritional status and lung function in cystic fibrosis: Cross sectional and longitudinal analyses from the German CF quality assurance (CFQA) project. Thorax 2002; 57: 596-601.
13. Yankaskas JR, Marshall BC, Sufian B, Simon RH, Rodman D,. Cystic fibrosis adult care. Consensus conference report. Chest 2004; 125: 1S-39S.
14. Donatello S, Roberto B, Ermanno B, et al. An overview of international literature from cystic fibrosis registries: 2. Neonatal screening and nutrition/growth. J. Cyst. Fibros. 2010; 9: 75-83.
15. diSant'Agnese P, Davis PB,. Cystic fibrosis in adults: 75 cases and a review of 232 cases in the literature. Am. J. Med. 1979; 66: 121-132.
16. Haroun D, Wells J, Lau C, Hadji-Loucas E, Lawson M,. Assessment of obesity status in outpatients from three disease states. Acta Paediatr. 2006; 95: 970-974.
17. Kastner-Cole D, Palmer C, Ogston S, Mehta A, Mukhopadhyay S,. Overweight and obesity in ΔF508 homozygous cystic fibrosis. J. Pediatr. 2005; 147: 402-404.
18. Baylor College of Medicine. USDA/ARS Children's Nutrition Research Center. Children's BMI-percentile-for-age Calculator, 2004 [Cited 2 October 2010.] Available from URL: http://www.bcm.edu/cnrc/bodycomp/bmiz2.html
19. Lai HJ,. Classification of nutritional status in cystic fibrosis. Curr. Opin. Pulm. Med. 2006; 12: 422-427.
20. Zhang Z, Lai HJ,. Comparison of the use of body mass index percentiles and percentage of ideal body weight to screen for malnutrition in children with cystic fibrosis. Am. J. Clin. Nutr. 2004; 80: 982-991.
21. Cystic Fibrosis Foundation. CCF. Cystic Fibrosis Foundation Patient Registry. 2008 Annual Data Report. 2009; Volume: 7-8. [Cited 10 August 2012.] Available from URL: http://www.cff.org/UploadedFiles/research/ClinicalResearch/ 2008-Patient-Registry-Report.pdf
22. Stallings VA, Stark LJ, Robinson KA, Feranchak AP, Quinton H,. Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: Results of a systematic review. J. Am. Diet. Assoc. 2008; 108: 832-839.
23. National Institutes of Health. Bioelectrical Impedance Analysis in Body Composition Measurement. Technology Assessment Statement. National Institutes of Health, 1994.
24. Moran A, Brunzell C, Cohen RC, et al. Clinical care guidelines for cystic fibrosis-related diabetes. Diabetes Care 2010; 33: 2697-2708.
25. Colombo C,. Liver disease in cystic fibrosis. Curr. Opin. Pulm. Med. 2007; 13: 529-536.
26. Alberti K, Zimmet P, Shaw J,. Metabolic syndrome: A new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet. Med. 2006; 23: 469-480.
27. Lai HJ, Shoff SM,. Classification of malnutrition in cystic fibrosis: Implications for evaluating and benchmarking clinical practice performance. Am. J. Clin. Nutr. 2008; 88: 161-166.
28. Lucidi V, Alghisi F, Raia V, et al. Growth assessment of paediatric patients with CF comparing different auxologic indicators: A multicentre Italian study. J. Pediatr. Gastroenterol. Nutr. 2009; 49: 335-342.
29. Dray X, Kanaan R, Bienvenu T, et al. Malnutrition in adults with cystic fibrosis. Eur. J. Clin. Nutr. 2005; 59: 152-154.
30. Kosinska M, Szwed A, Cieslik J, Gozdzik J, Cofta S,. Biological status of adult patients with cystic fibrosis. J. Physiol. Pharmacol. 2008; 59: 341-348.
31. da Silva Pinto IC, da Silva CP, de Britto MCA,. Nutritional, clinical and socioeconomic profile of patients with cystic fibrosis treated at a referral center in northeastern Brazil. J. Bras. Pneumol. 2009; 35: 137-143.
32. Fotoulaki M, Vasilaki K, Poulou M, et al. p.F508del homozygosity and the genotype-phenotype relationship in Northern Greece. (Abstract 373). J. Cyst. Fibros. 2011; 10: S95-S95.
33. Valletta E, Fornaro M, Cippolli M, Conte S, Bissolo F, Danchielli C,. Celiac disease and obesity: Need for nutritional follow-up after diagnosis. Eur. J. Clin. Nutr. 2010; 64: 1371-1372.
34. Stack M, Mahony M, Boyle C,. Obesity in childhood cystic fibrosis (Abstract 220). J. Cyst. Fibros. 2007; 6 (Suppl.): S54.
35. Munck A, Bellis G, Ravilly S, Huet F,. Do overweight and obesity improve clinical outcome in the French cystic fibrosis population? (Abstract 221). J. Cyst. Fibros. 2007; 6 (Suppl.): S54.
36. Sidoroff V, Hyvärinen M, Piippo-Savolainen E, Korppi M,. Lung function and overweight in school aged children after early childhood wheezing. Pediatr. Pulmonol. 2010; 45: 435-441.
37. Sebro R, Levy H, Schneck K, et al. Cystic fibrosis mutations for p.F508del compound heterozygotes predict sweat chloride levels and pancreatic sufficiency. Clin. Genet. 2012; 82: 546-551.
38. Pedreira C, Robert R, Dalton V, et al. Association of body composition and lung function in children with cystic fibrosis. Pediatr. Pulmonol. 2005; 39: 276-280.